8-KOther Events

HCA Healthcare, Inc. 8-K Report (Jul 14, 2004)

Filed July 14, 2004For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on July 14, 2004, primarily to disclose its earnings expectations for the second quarter ended June 30, 2004. This filing serves as a mechanism to broadly disseminate material information to investors, aligning with Regulation FD. The company is preemptively communicating its anticipated financial performance ahead of the official earnings release. Investors should note that this 8-K is a disclosure of forward-looking statements regarding HCA's expected financial results for Q2 2004. While specific figures are not detailed within the 8-K itself (as they are referenced in Exhibit 99.1, a press release), this filing signals the company's proactive approach to investor communications regarding its performance.

Key Highlights

  • 1HCA Inc. filed an 8-K on July 14, 2004.
  • 2The filing's primary purpose is Regulation FD Disclosure.
  • 3HCA announced earnings expectations for the second quarter ended June 30, 2004.
  • 4The detailed press release containing the earnings expectations is attached as Exhibit 99.1.
  • 5This filing ensures broad public dissemination of the company's Q2 2004 performance outlook.
  • 6The event date and filing date are both July 13, 2004, indicating immediate disclosure.
  • 7This preemptive communication aims to manage investor expectations regarding financial results.

Frequently Asked Questions

The main purpose of this 8-K filing is to comply with Regulation FD by publicly disclosing HCA's earnings expectations for the second quarter ended June 30, 2004, via an attached press release.

This 8-K filing itself does not contain the specific earnings numbers. It references a press release (Exhibit 99.1) which is expected to contain the detailed earnings expectations for the second quarter of 2004.

HCA filed this 8-K to ensure that any material information regarding their anticipated earnings for Q2 2004 is broadly disseminated to all investors simultaneously, in compliance with Regulation Fair Disclosure (FD) rules.

Regulation FD Disclosure means that HCA is making its earnings expectations public to prevent selective disclosure to any single investor or group of investors. This ensures a level playing field for all market participants.